Ketamine and Suicidal Ideation: The Rapid Anti-Suicidal Effect

Suicidal ideation — thoughts of ending one's life — is one of the most urgent and dangerous symptoms in psychiatry. It is also one of the most difficult to treat quickly. Standard antidepressants take 4–8 weeks to work, and during that window, patients remain at risk.

Ketamine has emerged as a genuinely revolutionary treatment for suicidal ideation, producing rapid, dramatic reductions in suicidal thoughts — often within hours of a single infusion. This anti-suicidal effect appears to be independent of ketamine's antidepressant effect, suggesting a distinct mechanism that directly targets the neurobiology of suicidality.

At Roth Family Medicine & Mental Health in Pocatello, Idaho, we take suicidal ideation seriously and offer ketamine therapy as part of a comprehensive, safety-focused approach to patients experiencing suicidal thoughts.

Suicide is the 10th leading cause of death in the United States and the 2nd leading cause of death among people aged 10–34. In Idaho, suicide rates are significantly above the national average — Idaho consistently ranks among the top 10 states for suicide mortality.

For patients experiencing suicidal ideation, the standard of care has historically involved:

• Hospitalization for safety monitoring
• Initiation of antidepressants (with a 4–8 week onset)
• Psychotherapy
• Safety planning

While these interventions are important, they leave a critical gap: the acute period of suicidal crisis, when patients are at highest risk, is not addressed by treatments that take weeks to work.

Ketamine fills this gap.

The evidence for ketamine's rapid anti-suicidal effect has grown substantially over the past decade:

2010 — Murrough et al.: One of the first studies to specifically examine suicidal ideation as an outcome found that a single IV ketamine infusion produced significant reductions in suicidal ideation within 24 hours in patients with treatment-resistant depression.

2014 — Murrough et al. (RCT): A randomized controlled trial found that ketamine produced significantly greater reductions in suicidal ideation compared to midazolam (active placebo) within 24 hours, with effects independent of its antidepressant effects.

2018 — Grunebaum et al.: A study specifically in patients with major depression and significant suicidal ideation found that ketamine produced rapid, significant reductions in suicidal ideation compared to midazolam, with effects lasting up to 6 weeks after a single infusion.

2020 — Wilkinson et al.: A meta-analysis of 15 studies found that ketamine produced rapid, significant reductions in suicidal ideation across diverse patient populations, with effects apparent within hours and lasting days to weeks.

2021 — Emergency department studies: Multiple studies in emergency department settings found that IV ketamine significantly reduced suicidal ideation in acutely suicidal patients, with effects apparent within 1–4 hours.

The consistency of these findings across multiple study designs, patient populations, and clinical settings is remarkable. Ketamine's anti-suicidal effect is one of the most replicated findings in recent psychiatric research.

Ketamine's anti-suicidal effect appears to involve several distinct mechanisms:

Suicidal ideation is associated with reduced activity and connectivity in the prefrontal cortex — the brain region responsible for rational thinking, perspective-taking, and impulse control. Ketamine rapidly rebuilds synaptic connections in the PFC within hours, restoring the cognitive capacity to evaluate and regulate suicidal thoughts.

Suicidality is closely linked to anhedonia — the inability to feel pleasure or anticipate positive future experiences. When the future feels uniformly bleak and empty, suicide can seem logical. Ketamine rapidly restores dopaminergic reward circuitry, allowing patients to re-engage with reasons for living.

Ketamine's dissociative properties may temporarily reduce the intensity of psychological pain — the unbearable suffering that drives suicidal ideation. This "pain relief" effect may be part of why patients often report feeling dramatically better within hours of an infusion.

Emerging research suggests that ketamine's anti-suicidal effect may be partially mediated through the opioid system — specifically through kappa-opioid receptor antagonism. Kappa-opioid receptors, when activated, produce dysphoria, hopelessness, and suicidal ideation. Ketamine's blockade of these receptors may directly reduce the emotional state that drives suicidality.

Neuroinflammation is elevated in suicidal patients and may contribute to the hopelessness and cognitive rigidity characteristic of suicidal crises. Ketamine's anti-inflammatory effects in the brain may contribute to its anti-suicidal properties.

Ketamine's speed of onset is unmatched among pharmacological treatments. For patients in acute suicidal crisis, this speed can be life-saving.

• Rapidly reduce the intensity of suicidal thoughts (often within hours)
• Restore the cognitive and emotional capacity to engage with safety planning and therapy
• Provide a window of relief during which longer-term treatments can take effect
• Reduce the hopelessness and anhedonia that drive suicidal ideation
• Potentially reduce the risk of suicide attempt in the acute period

• Eliminate the underlying conditions that cause suicidal ideation (depression, PTSD, chronic pain, etc.)
• Replace comprehensive psychiatric care, safety planning, and psychotherapy
• Guarantee safety — suicidal ideation can return, and ongoing monitoring is essential
• Substitute for emergency psychiatric evaluation when a patient is in immediate danger

Ketamine is most effective as part of a comprehensive treatment plan that includes ongoing psychiatric care, therapy, safety planning, and social support.

We take suicidal ideation seriously and approach it with both urgency and compassion. Our protocol for patients experiencing suicidal thoughts includes:

Comprehensive safety assessment: We evaluate the severity of suicidal ideation, presence of a plan or intent, access to means, protective factors, and level of support. This assessment determines the appropriate level of care.

Collaborative safety planning: We work with patients to develop a personalized safety plan — identifying warning signs, coping strategies, reasons for living, and emergency contacts.

Coordination of care: We work closely with therapists, psychiatrists, and other providers to ensure comprehensive, coordinated care.

Ketamine evaluation: For patients with significant suicidal ideation who are appropriate candidates, we discuss ketamine therapy as an option for rapid symptom relief.

Clear emergency protocols: Every patient knows exactly what to do if their suicidal ideation intensifies — including crisis line numbers, emergency contacts, and when to go to the emergency room.

Ketamine for suicidal ideation may be appropriate for patients who:

• Have significant suicidal ideation in the context of depression, PTSD, or other treatable conditions
• Are not in immediate danger (i.e., do not require inpatient hospitalization)
• Have not responded adequately to standard antidepressants
• Are medically stable and do not have contraindications to ketamine
• Have a support system and safety plan in place
• Are committed to ongoing psychiatric care and therapy

Ketamine is not a substitute for emergency psychiatric care. Patients who are in immediate danger, have a specific plan and intent to act, or cannot be safely managed in an outpatient setting require emergency evaluation and possible hospitalization.

If you are experiencing suicidal thoughts and are in immediate danger, please:

• Call 988 (Suicide and Crisis Lifeline — call or text, 24/7)
• Call 911 or go to your nearest emergency room
• Call or text a trusted person who can be with you

You are not alone, and help is available right now.

If you're in Pocatello, Chubbuck, Bannock County, or Southeast Idaho and you're experiencing suicidal ideation — or if you're a family member concerned about a loved one — please reach out to us.

At Roth Family Medicine & Mental Health, we offer compassionate, comprehensive care for patients with suicidal ideation, including ketamine therapy for rapid relief and ongoing mental health support.

Call us at (208) 904-4705 or book online. We're accepting new patients and are committed to providing the highest level of care for patients in crisis.

• Ketamine produces rapid, dramatic reductions in suicidal ideation — often within hours of a single infusion
• This anti-suicidal effect appears to be independent of ketamine's antidepressant effect
• Mechanisms include rapid PFC synaptogenesis, restoration of reward circuitry, and kappa-opioid receptor antagonism
• Ketamine is not a substitute for emergency psychiatric care but can be life-saving in the acute period
• Idaho has above-average suicide rates, making access to rapid-acting treatments particularly important
• Ketamine works best as part of a comprehensive treatment plan including therapy, safety planning, and ongoing psychiatric care

If you are in immediate danger, please call 988 or 911. This article is for informational purposes only and does not constitute medical advice.

Kyle Roth, FNP-BC, APRN, MSN, MHA is a board-certified family nurse practitioner specializing in ketamine therapy, TMS therapy, and treatment-resistant depression at Roth Family Medicine & Mental Health in Pocatello, Idaho.